There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Day One Biopharmaceuticals (DAWN – Research ...
Researchers have developed a sustainable catalyst that increases its activity during use while converting carbon dioxide (CO2) into valuable products. This discovery offers a blueprint for designing ...
Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) in the fourth quarter, HoldingsChannel.com reports. The institutional investor bought 484,666 shares of the biopharmaceutical company’s stock ...
The stock's fall snapped a three-day winning streak.
Shares of Catalyst Pharmaceuticals Inc. CPRX rose 1.34% to $23.40 Wednesday, on what proved to be an all-around favorable ...
6d
Hosted on MSNBaird Initiates Coverage of Catalyst Pharmaceuticals (CPRX) with Outperform RecommendationFintel reports that on February 4, 2025, Baird initiated coverage of Catalyst Pharmaceuticals (NasdaqCM:CPRX) with a Outperform recommendation. Analyst Price Forecast Suggests 47.68% Upside As of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results